Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06515184 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Coenzyme Q10 for Gulf War Illness: A Replication Study

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv5
  2. Primary endpoint revised Secondary endpoints: details revised at 7 of 7 entriesv4 Show 1 more changeShow less
    • Secondary endpoints: details revised at 7 of 7 entries

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jul 2024 to Sep 13, 2024 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Jul 2024 to Sep 13, 2024
    • Site details revised
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess whether a high quality preparation of ubiquinone (coenzyme Q10) benefits symptoms, function, and quality of life in veterans with Gulf War illness.
Trial Details
NCT Number NCT06515184
Lead Sponsor University of California, San Diego
Collaborators: United States Department of Defense
Conditions Gulf War Syndrome, Persian Gulf Syndrome, Mitochondrial Disorder, Respiratory Chain
Enrollment 192 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov